KDR and ovarian neoplasm: ECM alterations in terms of composition and organization were observed in Sk-Mel-31 melanoma xenografts expressing the oncogenic VEGFR2<sup>R1032Q</sup> and in ovarian tumors with VEGFR2 hyperactivation.